Anthony J Gill
@CaDxPath
Professor of Surgical Pathology & Pathologist University of Sydney Head Cancer Diagnosis & Pathology Research Group. Member of the Order of Australia (AM)
Infarct necrosis important to separate from true tumour necrosis in NETs.2 show true necrosis(abrupt transition, karyorrhectic debris, comedo-like)& 2 show infarct(gradual transition, zonal granulation tissue/myobroblasts) If you think easy -> retweet If you think hard -> like
Hi #pathtwitter Sorry I have been absent, but I have moved jobs! I am now working in Perth, Australia for Pathwest and (soon for) @uwanews (as A/Prof). Will get back to posting soon, in the meantime, here is an interesting colleague's case. #GIpath #Endopath #Pathresidents
Skin lesion 40 year old male. Who else always undertakes fumarate hydratase IHC and 2SC IHC in cutaneous leiomyomas. We always do. Practice hint, immunohistochemistry for FH can be difficult to interpret in cutaneous leiomyomas. This is because they are always associated with…
An international inter‐rater agreement study in the challenging diagnosis of squamous dysplasia of the oesophagus - Patil - Histopathology - Wiley Online Library #gipath onlinelibrary.wiley.com/doi/10.1111/hi…
Very pleased to share an online piece brought to you by the CAP Personalized Health Care Committee. By Dr. Maria Del Carmen Rodriguez Pena and yours truly. IHC in soft tissue tumor pathology! cap.org/member-resourc… #PathTwitter #molpath #surgpath #BSTpath @Pathologists
I am a very proud Tasmanian (as many will know) and I am very proud to be a graduate of the University of Tasmania, having completed my undergraduate medical degree there in 1990. My education there had a big impact on my medical and academic career, and my scientific drive to…
I post this every year because I am very interested in how the impact factors in pathology journals change over time and the approaches editors use to keep them high. A few points: 1. Since 2022 the impact factors have generally decreased - this correlates with a change in…
Big news! Endocrine Pathology now holds an Impact Factor of 14.7 - ranking us #2 out of 90 pathology journals. A huge thanks to our authors, reviewers, and readers. Submit your outstanding research and be part of the momentum!
One of the true greats of pathology . . . a great painting that captures the essence of the man
Honoring a legend: A beautiful tribute to Dr. Christopher Fletcher—visionary leader, world-renowned soft tissue pathologist, and mentor to many. Portrait by Dr. Christopher French. Thank you, Dr. French, for capturing the spirit of a true icon in pathology. 💫 #PathTwitter
Today I completed my 250th Parkrun down at the Greenway. I feel so touched at how many people showed up to demonstrate their support and kindness. Parkrun is such an important staple in my week and a fantastic, volunteer-run organisation who make it easy and accessible for anyone…
🚨 @ASCO #ASCO25 was absolutely incredible! 🧬✨ So many groundbreaking advances in oncology and exciting publications that are going to change patient care. 👉Sharing the key ones below @TheLancet @TheLancetOncol @JCO_ASCO @JAMA_current @JAMAOnc @CD_AACR - Also added the…
Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning
Hello, I'm reaching out to the #PathTwitter community to connect with Spanish pathology interns. I'd love to ask a few questions about your practice. Please feel free to contact me privately. Thanks!
Epithelioid Angiosarcoma
Liver lesion - what could it be? If you're not confident on H&E - some additional IHCs are in the thread
In @Nature from @StanfordMed by @max_diehn & @AshAlizadeh An ultrasensitive method for detection of cell-free RNA nature.com/articles/s4158… RARE-seq has a limit of detection of 0.05%, identifies ~30% of stage 1 lung cancers, and provides information on resistance mechanisms.
The IHC is both nuclear and cytoplasmic. It is CAMTA1. The tumours is also positive for endothelial markers and cytokeratins - therefore it is EPITHELIOID HAEMANGIOENDOTHELIOMA
Tumour in lung. Odd looking tumour present in vessels and lymph nodes. The IHC is definitive but stains a bit weaker in the tumour in vessels than in the lymph node. But what is the IHC marker and therefore what is the tumour?